E
Keros Therapeutics, Inc. KROS
$11.58 $0.110.96%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 2,250.99% 8,037.50% -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 2,250.99% 8,037.50% -- -- --
Cost of Revenue 29.91% -63.86% -73.31% -78.81% -83.86%
Gross Profit -5.84% 64.39% 73.56% 79.04% 84.04%
SG&A Expenses 16.99% 19.41% 25.84% 27.72% 26.55%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 26.04% 31.67% 34.81% 38.80% 48.18%
Operating Income -24.06% -31.26% -34.62% -38.62% -48.05%
Income Before Tax -22.26% -27.45% -32.81% -37.84% -46.15%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -22.46% -27.45% -32.81% -37.84% -46.15%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -22.46% -27.45% -32.81% -37.84% -46.15%
EBIT -24.06% -31.26% -34.62% -38.62% -48.05%
EBITDA -23.93% -31.11% -34.46% -38.68% -48.21%
EPS Basic 3.52% -5.26% -13.01% -16.74% -25.19%
Normalized Basic EPS 3.66% -5.27% -13.01% -16.74% -25.18%
EPS Diluted 1.58% -5.42% -42.33% -46.95% -57.25%
Normalized Diluted EPS 3.66% -5.27% -13.01% -16.74% -25.18%
Average Basic Shares Outstanding 27.13% 21.34% 18.71% 18.79% 16.69%
Average Diluted Shares Outstanding 27.13% 21.34% 18.71% 18.79% 16.69%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings